capecitabine has been researched along with Deficiency, Vitamin D in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demlova, R; Hacker, U; Hasenclever, D; Lordick, F; Obermannova, R; Selingerova, I; Valik, D; Zdrazilova-Dubska, L | 1 |
1 trial(s) available for capecitabine and Deficiency, Vitamin D
| Article | Year |
|---|---|
High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impact.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cetuximab; Cisplatin; ErbB Receptors; Female; Humans; Male; Middle Aged; Prevalence; Prognosis; Stomach Neoplasms; Treatment Outcome; Vitamin D; Vitamin D Deficiency | 2019 |